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Purpose: To evaluate the reproducibility of indices of lung
microstructure and function derived from 129Xe chemical shift
saturation recovery (CSSR) spectroscopy in healthy volunteers
and patients with chronic obstructive pulmonary disease
(COPD), and to study the sensitivity of CSSR-derived parame-
ters to pulse sequence design and lung inflation level.
Methods: Preliminary data were collected from five volunteers
on three occasions, using two implementations of the CSSR
sequence. Separately, three volunteers each underwent CSSR
at three different lung inflation levels. After analysis of these
preliminary data, five COPD patients were scanned on three
separate days, and nine age-matched volunteers were
scanned three times on one day, to assess reproducibility.
Results: CSSR-derived alveolar septal thickness (ST) and
surface-area-to-volume (S/V) ratio values decreased with lung
inflation level (P<0.001; P¼0.057, respectively). Intra-subject
standard deviations of ST were lower than the previously
measured differences between volunteers and subjects with
interstitial lung disease. The mean coefficient of variation (CV)
values of ST were 3.961.9% and 6.06 4.5% in volunteers
and COPD patients, respectively, similar to CV values for
whole-lung carbon monoxide diffusing capacity. The mean CV
of S/V in volunteers and patients was 14.16 8.0% and
18.06 19.3%, respectively.
Conclusion: 129Xe CSSR presents a reproducible method for
estimation of alveolar septal thickness. Magn Reson Med
000:000–000, 2016. VC 2016 The Authors Magnetic
Resonance in Medicine published by Wiley Periodicals,
Inc. on behalf of International Society for Magnetic Reso-
nance in Medicine. This is an open access article under
the terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in any
medium, provided the original work is properly cited.
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INTRODUCTION
Over the past two decades, hyperpolarized gas MRI with
3He and 129Xe has become a well-established functional
research tool for assessment of lung ventilation and
microstructure (1–3). In recent years, a number of MR
techniques have been developed to study pulmonary gas
exchange with hyperpolarized 129Xe (4–6), exploiting the
solubility of xenon in somatic substances and the large
chemical shift difference of 129Xe in lung tissue and
blood plasma (T/P) and red blood cells (RBCs) (corre-
sponding to resonances at 197 and 218 ppm downfield
from the 129Xe gas resonance, respectively). Notably, the
chemical shift saturation recovery (CSSR) method (7–9)
allows monitoring of gas exchange dynamics through
acquisition of NMR spectra from the lungs at different
delay times after selective saturation of the 129Xe mag-
netization in T/P and RBCs. This method has been
shown to provide clinically relevant metrics of gas
exchange impairment, enabling estimation of interstitial
(septal) tissue thickening in interstitial lung disease
(ILD), including idiopathic pulmonary fibrosis (IPF)
(8,10), and inflammation in chronic obstructive pulmo-
nary disease (COPD) (11).
Previous studies with 129Xe CSSR in human subjects
have been limited to small patient cohorts, and the
reproducibility of the technique has yet to be assessed.
The reproducibility of MR-derived functional measures
is critical to determining their sensitivity and robustness
for future clinical applications as a quantitative outcome
measure (12). For example, though the efficacy of 3He
apparent diffusion coefficient mapping for characteriza-
tion of emphysema has been well-known for many years
(13), the reproducibility of the technique is key to facili-
tating increased application in a clinical setting (14,15).
Similarly, 129Xe CSSR-derived measures of pulmonary
gas exchange must be demonstrated to be sufficiently
reproducible before the sensitivity of the method to
disease-related changes in lung structure/function can be
adequately assessed.
In this work, the intra-subject reproducibility of
129Xe CSSR-derived quantitative parameters of lung
microstructure and function was evaluated in COPD
patients and age-matched healthy volunteers. Addi-
tionally, the sensitivity of the technique to MR pulse
sequence strategy and to lung inflation state was exam-
ined by measuring the reproducibility of two existing
implementations of the CSSR sequence, and perform-
ing CSSR experiments at different inflation levels in
healthy volunteers, respectively.
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METHODS
This study was divided into two parts: (i) preliminary
investigations of the reproducibility and robustness of
performance of two different pulse sequence implemen-
tations of the CSSR method, and quantification of the
effect of lung inflation level on CSSR-derived parameters
in healthy volunteers; and (ii) reproducibility measure-
ments with one implementation of the CSSR sequence at
fixed inflation level in COPD patients and age-matched
healthy volunteers.
Preliminary study (i): Five healthy volunteers (mean
age6 standard deviation, 386 14 years) with no history
of respiratory disease were recruited (demographics
given in Table 1). To examine the reproducibility of two
different implementations of the CSSR sequence existing
in the literature, each subject was scanned on three sepa-
rate days over a period of 1–3 weeks on a 1.5 T GE HDx
whole-body MR system (GE Healthcare, Milwaukee, Wis-
consin, USA). The two implementations of the 129Xe
CSSR sequence are hereafter defined as the “multi-
sweep” and “multi-sat” sequences (Fig. 1), referring to
FIG. 1. Schematic representation of the two implementations of the 129Xe CSSR pulse sequence used in this work: (a) 90  RF saturation
pulses separated by a variable wait period (equivalent to the inter-pulse repetition time); whole acquisition repeated three times (termed
“multi-sweep” CSSR); (b) multiple RF saturation pulses with a short inter-pulse delay, followed by a variable wait period; whole time
series acquired once (“multi-sat” CSSR); (c) typical time series of 129Xe NMR spectra acquired using the sequence shown in (a), normal-
ized to the gas peak. T/P, 129Xe dissolved in tissues and blood plasma; RBC, 129Xe in red blood cells.
Table 1
Subject Demographics, Pulmonary Function Tests, and Reproducibility of 129Xe CSSR ST and S/V Data
Demographics PFT parameters MRI measurements
Group
Age
(sex)
FEV1
(% pred)
CV
(%)
FEV1/FVC
(% pred)
CV
(%)
DLCO
(% pred)
CV
(%)
Mean ST
(mm)a
CV
(%)
Mean
S/V (cm1)a
CV
(%)
HV1 24 (M) 107.8 — 97.5 — — — 11.16 0.3 2 286.7671.8 25
HV1 32 (F) 115.8 — 91.9 — — — 10.56 0.5 5 259.9649.8 19
HV1 42 (M) 97.7 — 93.9 — — — 12.46 0.7 5 237.7668.0 29
HV1 63 (F) 119.7 — 101.3 — — — 12.66 0.6 5 171.8662.0 36
HV1 28 (M) 107.8 — 89.4 — — — 11.06 0.4 3 186.3630.8 17
HV1 31 (M) 88.9 — 88.3 — — — 11.9 — 145.7 —
HV2 59 (F) 100.8 — 97.8 — — — 13.56 0.4 3 164.2644.2 27
HV2 55 (M) 92.3 — 96.6 — — — 12.66 0.3 3 238.6629.4 12
HV2 63 (M) 100.9 — 93.0 — — — 12.36 0.7 6 154.7641.2 27
HV2 58 (M) 105.1 — 98.0 — — — 11.46 0.6 5 261.8639.0 15
HV2 58 (F) 79.2 — 105.5 — — — 11.46 0.4 4 180.469.2 5
HV2 62 (M) 97.3 — 93.7 — — — 10.56 0.1 1 185.5624.5 13
HV2 40 (F) 110.3 — 101.3 — — — 10.96 0.6 5 84.465.2 6
HV2 54 (M) 101.5 — 106.3 — — — 11.56 0.3 3 322.8624.7 8
HV2 66 (M) 90.1 — 101.6 — — — 10.66 0.7 7 155.9621.4 14
COPD 64 (F) 31.56 0.7 2 33.26 0.6 2 33.262.1 6 14.36 1.8 12 70.969.4 13
COPD 67 (F) 45.46 1.6 4 49.86 0.7 1 98.463.8 4 9.66 0.3 3 215.86 105.8 49
COPD 71 (M) 31.06 1.3 4 27.66 1.1 4 13.662.2 16 14.16 1.2 9 75.561.8 2
COPD 76 (M) 43.56 2.1 5 32.56 0.8 3 29.662.0 7 16.56 0.3 2 90.562.2 2
COPD 59 (F) 38.66 2.5 6 42.86 0.8 2 38.064.1 11 15.76 0.6 4 130.0629.9 23
HV1, healthy volunteers recruited for preliminary investigations; HV2, age-matched healthy volunteers recruited for reproducibility tests;
COPD, patients with chronic obstructive pulmonary disease recruited for reproducibility tests; PFT, pulmonary function test; FEV1, forced
expiratory volume in one second; FVC, forced vital capacity; DLCO, diffusing capacity of carbon monoxide; ST, septal thickness; S/V,
surface-area-to-volume ratio; CV, coefficient of variation; % pred, pulmonary functional parameters expressed as a percentage of a pre-
dicted value, based on demographic factors such as age and height.
aAll values derived from scans at FRCþ1L using the multi-sweep sequence.
2 Stewart et al
the use of multiple sweeps over different TR values, and
multiple saturation pulses per TR interval, respectively.
The multi-sweep sequence uses single saturation pulses
to destroy the magnetization of 129Xe dissolved in T/P
and RBCs, followed by a variable inter-pulse wait period
(repetition time (TR)), during which alveolar-capillary
gas exchange occurs and polarized 129Xe gas diffuses
into the T/P and RBC compartments. Multiple repeats of
the TR sweep are acquired and averaged (10). The
sequence parameters used were the same as in (10):
binomial-composite radiofrequency pulses were used for
selective saturation of dissolved 129Xe (16); spectra were
acquired with a bandwidth of 12 kHz and 64 sampling
points; 25 TR settings from 20–1000 ms were swept
through sequentially, and the whole TR sweep was
repeated three times and averaged. The multi-sat
sequence, as detailed in (11,17), employs multiple satu-
ration pulses before each variable wait period and
involves no averaging. This sequence was implemented
with the following parameters: radiofrequency (RF) pulse
and bandwidth as above; 128 sampling points (increased
relative to the multi-sweep implementation, because the
minimum achievable exchange time is not limited by the
read-out duration in the multi-sat sequence); and 21 TR
values from 20–1000 ms. In each case, a gas dose of 350–
400 mL xenon (86% 129Xe, polarized to 25% (18)), bal-
anced to 1 L with nitrogen, was inhaled from a TedlarV
R
bag (Jensen Inert Products, Coral Springs, FL) from func-
tional residual capacity (FRC) before a 10–15-s breath-
hold. CSSR data were fitted with the model of xenon
exchange (MOXE) (19), using a xenon diffusion coeffi-
cient in the dissolved phase of D¼ 3.0 x10-10 m2s-1 and
an Ostwald solubility coefficient of xenon in tissue of
0.1 (8), to estimate whole-lung alveolar septal thickness
(ST) and surface-area-to-volume ratio (S/V).
To investigate the change in CSSR-derived parameters
with lung inflation level, multi-sweep CSSR data were
acquired at three different lung inflation levels from
three healthy volunteers (24 (M), 28 (M), and 31 (M) in
Table 1). Sequence parameters were as above. The fol-
lowing inflation levels were attained before the breath-
hold and data acquisition: i) forced exhalation to resid-
ual volume (RV), followed by inhalation of the 1 L
xenon-nitrogen mixture; ii) exhalation to FRC, followed
by a 1 L inhalation; and iii) exhalation to FRC, followed
by inhalation of the 1 L dose and additional inhalation of
room air to reach total lung capacity (TLC).
Reproducibility measurements (ii): Nine healthy vol-
unteers (596 8 years) with no history of respiratory dis-
ease, and five patients with COPD (6766 years) were
recruited (see Table 1). To assess the short- and long-
term reproducibility of 129Xe CSSR, COPD patients were
scanned on four occasions; twice on the first day, once
the following day, and once two weeks later. Volunteers
were scanned in three separate sessions on the same
day, between which they were repositioned. In all cases,
the multi-sweep sequence was employed, with parame-
ters as previously and a xenon dosage of 300–350 mL.
For comparison with MR measurements, conventional
pulmonary function tests (PFTs) were performed by all sub-
jects (Table 1), including forced expiratory volume in 1 s
(FEV1) and forced vital capacity (FVC) maneuvers. In addi-
tion, the diffusing capacity of carbon monoxide (DLCO) test
was performed by COPD patients to provide a standard met-
ric of pulmonary gas exchange. For the two healthy volun-
teer cohorts, PFT data were acquired on only one occasion,
as the variability of spirometry is well-known in healthy
subjects (20), whereas for COPD patients, PFT data were
obtained on each of the three scan dates.
To evaluate the reproducibility of each CSSR-derived
functional parameter, the intra-subject standard devia-
tion (SD) and coefficient of variation (CV; the ratio of SD
to mean value, expressed as a percentage) was calcu-
lated. A mixed-model, repeated measures analysis of var-
iance test was performed for each parameter to
determine the significance of any time-dependent varia-
tions, according to the F-value (analogous to a conven-
tional statistical t-value) and P-value of significance.
Reproducibility data are presented as mean, SD, and CV
values and modified Bland-Altman plots (21) with CV
on the y-axis. An equivalent analysis was carried out for
PFT measurements where applicable.
RESULTS
In one participant from the age-matched healthy volun-
teer cohort (62 (M)), the signal-to-noise ratios (SNRs) of
the spectra obtained from one scan were insufficient to
fit meaningful estimates of alveolar ST and S/V. Addi-
tionally, another participant from this group (59 (F)) was
unable to maintain breath-hold for the duration of one
scan. Hence, only two data points were used for reprodu-
cibility analysis in these subjects. For two COPD patients
(64 (F) and 67 (F)), data were only successfully acquired
once on the first day of scanning, and in a third patient
(71 (M)), the spectral SNR was insufficient in one scan
from the first day. Thus, only three of the four proposed
acquisitions were available for reproducibility analysis
in these patients.
Preliminary study (i): Mean ST values in the five
healthy volunteers derived from multi-sweep and multi-
sat sequences were 11.560.9 mm and 12.66 1.2mm, and
the corresponding mean CV values of ST were 4.16
1.3% and 10.06 7.4%, respectively. The mean S/V val-
ues derived from the multi-sweep and multi-sat sequen-
ces were 228649 cm-1 and 1956 46 cm1, and the
corresponding mean CV values of S/V were 25.16 7.8%
and 23.7613.2%, respectively. Figure 2 depicts Bland-
Altman plots of the intra- and inter-subject variations of
ST and S/V parameters derived from the two sequences.
(The intra-subject variability (reproducibility) is repre-
sented by the CV axis.)
Mean ST values from the three healthy volunteers
were similar at inflation levels of RVþ 1 L (11.060.1 mm)
and FRCþ 1 L (11.36 0.5mm), whereas the ST was signif-
icantly reduced (P<0.001) at TLC (7.66 0.5mm) when
compared with both RVþ 1 L and FRCþ 1 L, as shown in
Figure 3a. S/V values exhibited a decreasing trend with
inflation level (Fig. 3b), with a significance of P¼ 0.057
between TLC (115616 cm1) and RVþ 1 L (2536
66 cm1) (S/V at FRCþ 1 L was 2006 62 cm1).
Reproducibility measurements (ii): The average of the
mean ST in COPD patients (14.06 2.7mm) was elevated
when compared with age-matched healthy volunteers
(11.661.0 mm) (P< 0.05). Additionally, evidence of a
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reduced S/V ratio in COPD patients (117660 cm1)
when compared with volunteers (194670 cm1) was
observed (P¼ 0.055). The mixed-model analyses showed
no significant changes in ST or S/V as a function of scan
time point, with F¼ 1.32, P¼ 0.294 and F¼2.48,
P¼ 0.116 for healthy volunteers; F¼ 2.08, P¼0.156 and
F¼ 0.27, P¼ 0.845 for COPD subjects, concerning ST and
S/V, respectively. CV values of ST were <8% and <13%
in volunteers and COPD patients, with a mean6
standard deviation of 3.96 1.9% and 6.064.5%, respec-
tively (see Figs. 4a and 4c). CV values of S/V were< 28%
and <50% in volunteers and COPD patients, with a mean6
standard deviation of 14.16 8.0% and 18.0619.3% (Figs. 4b
and 4d).
Average FEV1 and FEV1/FVC measurements were sig-
nificantly reduced in COPD patients when compared
with volunteers (P< 0.001) (Table 1). In patients, the
mean CV values associated with pulmonary function
tests were 4.26 1.5% for FEV1; 2.46 1.1% for FEV1/FVC;
and 8.86 4.8% for DLCO.
DISCUSSION
The observation of improved reproducibility (lower CV)
of ST for the multi-sweep compared with the multi-sat
implementation of 129Xe CSSR may be a result of the
reduction in variance of fitted data points arising from
the multiple-averaging process. Nevertheless, upon
separate analysis of the individual TR sweeps of the
multi-sweep data sets presented in Figure 2, no clear dif-
ference in the mean CV of ST or S/V values derived from
each of the sweeps—when compared with the multi-
sweep average—was observed, other than the CV of ST
of the first sweep being slightly higher than that of the
other two sweeps (mean CV of ST¼ 4.16 1.3% for all
sweeps, 5.561.3% for sweep 1, 3.562.4% for sweep 2,
3.76 1.5% for sweep 3). We suspect that the minor
increase in CV for the first sweep results from the fact
that this sweep is associated with the highest SNR data-
points, and is thus more sensitive to subtle changes in
the shape of the uptake curve between scans. The latter
two sweeps have lower SNR, and hence we postulate
FIG. 2. Preliminary investigation of the reproducibility of parameters derived from the two different implementations of the 129Xe CSSR
sequence, as assessed in five healthy volunteers. The coefficient of variation of CSSR-derived septal thickness and surface-area-
to-volume ratio values are plotted on Bland-Altman charts in (a) and (b), respectively. Solid lines represent the mean CV and dashed
lines denote62 standard deviations from the mean.
FIG. 3. Mean 129Xe CSSR-derived alveolar septal thickness (a) and alveolar surface-area-to-volume ratio (b) measurements as a function
of lung inflation level in three healthy volunteers. RV, residual volume; FRC, functional residual capacity; TLC, total lung capacity.
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that the fitting process results in a curve that approxi-
mates a noisier data set, such that subtle changes
between repeated scans may be less apparent. Addition-
ally, it is worth noting that the mean CV for the multi-
sat sequence is strongly influenced by an outlying data
point with a CV of ST of 22.7%, which resulted from an
anomalous ST value in one of the three repeated scans
for that subject. In the absence of this outlier, the mean
CV between the two implementations would be consider-
ably closer (mean CV of multisat CSSR would become
6.962.6% instead of 10.067.4%). Previously, multiple
saturation pulses have been required to completely
destroy the dissolved-phase 129Xe magnetization in
human subjects (8,11,17). However, the use of a custom
binomial-composite pulse design permits highly effective
saturation of magnetization with a single pulse (16). The
observation that the CV of S/V is similar between the
two sequence implementations implies that the satura-
tion process itself is reproducible, as the S/V is strongly
influenced by the early time points of the CSSR experi-
ment, in which incomplete saturation could cause signif-
icant effects. In light of the apparent improved
reproducibility of ST, the multi-sweep implementation
was employed for subsequent experiments.
The measured decrease in S/V and ST with lung infla-
tion level can be explained by the expansion of the
alveoli and stretching of the lung tissue at high inflation
levels, respectively (22). A reduction in CSSR-derived S/
V has been previously reported with lung inflation level
(23), and, although a change in CSSR-derived ST with
inflation level has not been reported, recent observations
of a decline in the ratio of 129Xe T/P- or RBC-to-gas-
phase resonances with increasing inflation level (11,24)
indicate a reduced contribution of the dissolved 129Xe
MR signal at higher inflation levels because of the lower
volume fraction of tissue and capillaries versus airspace.
Despite our observations, the interpretation of these data
must be carefully considered in terms of the meaning of
the different inflation levels. Although some recent 129Xe
CSSR studies in humans have used the same approach
as that described here to achieve a desired inflation level
(e.g. FRCþ 1 L) before data acquisition (17), others have
employed a procedure of quantifying a subject’s TLC
before MRI, and modifying the inhaled gas dose for each
subject to achieve an inflation level that equates to a spe-
cific fraction of that subject’s TLC (8,11). The latter pro-
cedure ensures that the lungs are at an equivalent level
of inflation in each subject, which should correspond to
a comparable alveolar geometry. The inflation level of
FRCþ1 L employed here may equate to a different frac-
tion of each subject’s TLC. In future work, it may be bet-
ter practice to calculate an inhaled gas dose such that
the lung inflation level would be proportionate between
subjects (e.g. 50% TLC), making comparisons among
subjects more physiologically meaningful.
Assuming that the derived variation in ST and S/V
with lung inflation level cannot be fully explained by
inter-subject differences in relative lung inflation level,
this observation is an important consideration for future
CSSR studies; it is crucial to carefully instruct the
FIG. 4. Reproducibility of 129Xe CSSR-derived alveolar septal thickness and surface-area-to-volume ratio values in COPD patients and
age-matched healthy volunteers. (a) and (b): ST and S/V values in healthy volunteers (mean age¼596 8 years). (c) and (d): ST and S/V
values in COPD patients (mean age¼676 6 years). Solid lines represent the mean CV and dashed lines denote6 2 standard deviations
from the mean.
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subject to ensure the desired inflation level is achieved
and the breath-hold is effectively maintained. It might be
expected that patients would better tolerate breath-holds
at higher inflation levels than FRCþ 1 L. Furthermore,
we might expect the reproducibility of derived ST and
S/V metrics at TLC to be improved when compared with
FRCþ1 L, because TLC represents an extreme limit of
lung inflation level, potentially easier to achieve for the
patient, whereas the patients’ perception of FRC may
vary between experiments. However, appropriate repro-
ducibility tests must be carried out at TLC before routine
129Xe CSSR scans are possible at that inflation level.
The mean ST and S/V values derived in this work are com-
parable to estimates obtained from alternative methods: ST
10mm from histological methods (25) including computer-
ized morphometry (26,27); and S/V in healthy volunteers
250 cm1 from histological methods (28) and 200–240 cm1
from hyperpolarized 3He diffusion-weighted MRI (29) (both
of these articles also reported a reduced S/V of50–150 cm1
in a range of patients with severe to mild emphysema). In
addition, our results are of the same order as those reported
in recent 129Xe CSSR studies with human subjects
(8,10,11,17). However, direct comparison of the absolute ST
and S/V values in this work and other 129Xe CSSR studies in
humans requires careful consideration of any discrepancies
in data acquisition and analysis approaches in those works,
as discussed below. A review of example literature references
for ST and S/V values and a detailed explanation of the chal-
lenges in directly comparing our values to those of other
129Xe CSSR studies in humans is included as supplementary
text in the online version of this article.
It is important to consider that the data presented in
this manuscript can be analyzed using models other than
MOXE (8,30,31). In previous work, we highlighted small
differences in CSSR-derived lung microstructural param-
eters resulting from some of these models (10). Further-
more, in addition to discrepancies in data analysis
procedure, most human studies with 129Xe CSSR to date
have been performed with slightly different assumptions
about the value of critical physical parameters
(8,10,11,17,19), such as the diffusion coefficient and Ost-
wald solubility of xenon in tissue, both of which have a
significant bearing on the absolute derived ST and S/V
estimates. A review of the approaches and assumptions
considered in each of these works is included as supple-
mentary text and Supporting Table S1 in the online ver-
sion of this article.
The mean intra-subject standard deviation of CSSR-
derived ST values of age-matched healthy volunteers
(0.466 0.21mm) is much less than the difference in mean ST
between healthy subjects and IPF patients (7mm) as quan-
tified previously (mean healthy subject ST¼ 10.06 1.6mm;
mean IPF patient ST¼ 17.26 1.1mm from (10)), and also
less than the 2.4mm mean difference between healthy sub-
jects and COPD patients as measured here. In addition, the
Bland-Altman plots in Figure 4 illustrate that the CV of ST
does not appear to change with the mean value. These fac-
tors, coupled with the generally low CV values from volun-
teers and COPD patients (<8% and <13%, respectively),
provide substantive evidence that the CSSR-derived ST is a
reproducible parameter. The CV of ST was comparable to
that of PFT metrics of gas exchange; mean CV values in
COPD patients were comparable to the reported long-term
variability of DLCO (9% (32)), whereas the CV in healthy vol-
unteers was of a similar magnitude to that of same-session
variability of DLCO (33).
In contrast, the mean CV values of S/V were above the
target range for reproducibility of DLCO. This constrains
the interpretation of apparent trends of reduced S/V in
COPD patients and changes with lung inflation level.
The S/V parameter is derived from the early time points
of the CSSR experiment, when the dissolved 129Xe
signal-to-noise ratio is lowest (7). In addition, it would
be expected that incomplete saturation of magnetization
would adversely affect the derived S/V more so than the
ST, because the latter is predominantly influenced by
later time points. Furthermore, the complexity of the
model of xenon exchange (19) and its multiple interde-
pendent fitting parameters may lead to inaccurate esti-
mates of S/V (whereas by definition of the model, it
could be expected that ST would be less influenced by
these interdependencies). A combination of these factors
may explain the relatively poor S/V reproducibility.
A further limitation of the reproducibility of the CSSR-
derived S/V in patients is the outlying data point (67
(F)), with 49% CV. This subject exhibited a lower ST
than all subjects, and although her FEV1 and FEV1/FVC
were<50% of the predicted value, her DLCO was 98.1%
predicted, comparable to that of healthy subjects. Further
study with larger patient populations and tighter lung
inflation level control is necessary to identify these out-
liers and further validate the S/V reproducibility.
For both ST and S/V metrics, the intra-subject repro-
ducibility was noticeably worse in COPD patients than
healthy volunteers, despite similar results obtained from
the mixed-model analysis. This may be partially
explained by the fact that patients were scanned on mul-
tiple days, whereas volunteers were scanned on a single
day. Because of poor-quality or failed scans on the first
day of the protocol, there was insufficient data available
to accurately separate COPD patient reproducibility into
same-day or multi-day reproducibility; hence, CV values
for these patients are dominated by inter-day variations.
Additionally, it is worth considering that the reproduci-
bility of the 129Xe CSSR measurement is dependent on a
variety of factors, including fluctuations in 129Xe polar-
ization, reproducibility of lung inflation level, and suc-
cessful maintenance of breath-hold for the scan duration;
the latter two factors depend heavily on the subject.
Patients may have difficulty in inhaling the complete
contents of the Tedlar bag, and/or may be less effective
in maintaining breath-hold for the scan duration. It is
possible to circumvent breath-hold failure in the third
sweep by analyzing data from the first or second sweeps
only. However, factors such as lung inflation level are
challenging to control, and it is prudent to carefully
instruct the patient on the exact details of the protocol
and perform training scans with bags of air before the
CSSR scan itself, in a similar manner to repeated pulmo-
nary function testing (34).
CONCLUSIONS
129Xe CSSR has been demonstrated to be a reproducible
method for noninvasive quantification of pulmonary
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microstructure and function through estimation of the
alveolar septal thickness. The ST coefficient of variation
was of a similar order to the variability of conventional
pulmonary function tests. Furthermore, the correspond-
ing standard deviation was less than the difference in ST
between healthy volunteers and COPD patients measured
here, and the volunteers and IPF patients measured pre-
viously. In future studies, the sensitivity of the technique
to antifibrotic treatment response, or early changes in
ILD, should be assessed to facilitate clinical application.
At present, the CSSR-derived alveolar surface-area-to-
volume ratio is not sufficiently reproducible for consid-
eration as a robust clinical biomarker.
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